Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Ir J Psychol Med ; 40(3): 430-436, 2023 09.
Article in English | MEDLINE | ID: mdl-35388786

ABSTRACT

OBJECTIVES: Restrictive interventions (seclusion, restraint and special observations) are used on psychiatric wards when there are no other means available to keep a patient or others safe. These measures can be traumatic, and the Mental Health Commission and the Health Service Executive are focused on minimising their use. We set out to determine whether, following a COVID related reduction in bed numbers on a high dependency psychiatric ward in St John of God Hospital in Dublin, there was a change in their incidence. METHODS: Data on restrictive interventions and challenging behaviours were gathered for 9-month periods before and after March 2020 when COVID related ward changes took place. Figures were also collected on seclusion and restraint for the previous 18 months for a longer-term view. Ward and hospital occupancy levels were also recorded. RESULTS: Between the two time periods, episodes of seclusion fell by 53% and episodes of restraint by 56%. The hours devoted to special observation declined by 30% and incidents of challenging behaviours fell by 26%. Ward occupancy levels fell by only 5%. The longer-term comparison of figures for seclusion and restraint point towards a downward trend from mid-2019 that was accentuated in the post-COVID period. CONCLUSIONS: The changes found may relate to reduced crowding on the ward or other COVID related factors such as the emphasis on social distancing and a shared sense of purpose on the ward. The longer-term trend points towards an emerging cultural shift. The challenge now is to sustain and build upon these changes.


Subject(s)
COVID-19 , Mental Disorders , Humans , Psychiatric Department, Hospital , Mental Disorders/psychology , Hospitalization , Hospitals, Psychiatric
2.
J Patient Rep Outcomes ; 4(1): 65, 2020 Aug 05.
Article in English | MEDLINE | ID: mdl-32757092

ABSTRACT

BACKGROUND: Approximately 7-10% of Parkinson's disease (PD) patients carry a GBA (Glucocerebrosidase) mutation (GBA-PD patients), which may influence the disease's clinical course. OBJECTIVES: This study aimed to explore the patient experience of GBA-PD and identify the most important symptoms and impacts to inform clinical trial measurement strategies. METHODS: Twenty PD patients (n = 15 GBA-PD; n = 5 idiopathic-PD) participated in qualitative interviews which explored concepts spontaneously reported or identified through a literature review. Telephone interviews with five expert clinicians included discussion of a preliminary conceptual model derived from literature. Verbatim transcripts were thematically analysed. RESULTS: Thirty symptoms reported by patients were categorized as motor, non-motor, and cognitive/psychiatric. Tremor (n = 13), memory loss (n = 13), rigidity/stiffness (n = 11), and speech problems (n = 11) were considered the most important and impactful symptoms by GBA-PD patients, although other symptoms were also relevant to the majority of patients. Key impacts included: sleep disturbances (n = 13), handwriting changes (n = 13), reduced social interaction (n = 12), dyskinesia (n = 10), depressed mood (n = 9), and fear of falling (n = 8). Key symptoms and impacts reported by GBA-PD patients were consistent with those reported by idiopathic-PD patients. Clinician interview results supported the patient findings, although some clinicians indicated that cognitive/psychiatric symptoms may present earlier in GBA-PD patients. The concepts emerging from the research informed updates to a conceptual model of GBA-PD patients' disease experience. CONCLUSIONS: The findings provide in-depth understanding of the patient experience of GBA-PD. The findings confirm that the concepts relevant to assess in GBA-PD are consistent with those relevant to assess in idiopathic-PD; however, greater consideration of cognitive/psychiatric symptoms may be warranted in GBA-PD populations.

4.
Nurs Times ; 94(35): 24-5, 1998.
Article in English | MEDLINE | ID: mdl-10026504
5.
Pediatrics ; 94(1): 53-8, 1994 Jul.
Article in English | MEDLINE | ID: mdl-8008538

ABSTRACT

OBJECTIVE: To provide empirical data on immunization coverage and the receipt of preventive health care to inform policy makers' efforts to improve childhood immunization. DESIGN AND METHODS: We surveyed a random sample drawn from a birth cohort of 557 2-year-old children living in the inner-city of Baltimore. Complete information on all their preventive health care visits and immunization status was obtained from medical record audits of their health care providers. MAIN OUTCOME MEASURES: Age-appropriate immunizations and preventive health care visits. RESULTS: By 3 months of age, nearly 80% made an age-appropriate preventive health visit, but by 7 months of age, less than 40% had a preventive visit that was age-appropriate. In the second year of life, 75% made a preventive health visit between their 12- and 17-month birthdays. The corresponding age-appropriate immunization levels were 71% for DTP1, 39% for DTP3, and 53% for measles-mumps-rubella vaccine. Infants who received their DTP1 on-time were twice as likely to be up-to-date by 24 months of age. CONCLUSIONS: Our analyses focus attention on the performance of the primary health care system, especially during the first 6 months of life. Many young infants are underimmunized despite having age-appropriate preventive visits, health insurance coverage through Medicaid, and providers who receive free vaccine from public agencies. Measles vaccination coverage could be improved by initiating measles-mumps-rubella vaccine vaccination, routinely, at 12 months among high risk populations.


Subject(s)
Preventive Health Services/statistics & numerical data , Urban Health , Vaccination/statistics & numerical data , Baltimore , Child, Preschool , Cohort Studies , Diphtheria-Tetanus-Pertussis Vaccine/therapeutic use , Drug Combinations , Humans , Immunization Schedule , Measles Vaccine/therapeutic use , Measles-Mumps-Rubella Vaccine , Mumps Vaccine/therapeutic use , Poliovirus Vaccine, Inactivated/therapeutic use , Poverty Areas , Rubella Vaccine/therapeutic use , Selection Bias
6.
Md Med J ; 42(8): 775-8, 1993 Aug.
Article in English | MEDLINE | ID: mdl-8412540

ABSTRACT

Maternal and Child Health Services in the Baltimore City Health Department, founded in 1934 and 1919, respectively, grew out of concern for maternal and infant death. Increasingly, services have focused on prevention and on building individual health by strengthening the family. The authors identify changing patterns of health care and the health department's continuing role in assuring high quality care and developing guidelines for cost-effective management.


Subject(s)
Maternal-Child Health Centers/history , Urban Health/history , Adult , Baltimore , Child, Preschool , Female , History, 20th Century , Humans , Infant , Infant, Newborn , Male , Pregnancy
SELECTION OF CITATIONS
SEARCH DETAIL
...